Acoziborole receives positive opinion for single-dose sleeping sickness treatment

https://www.news-medical.net/news/20260227/Acoziborole-receives-positive-opinion-for-single-dose-sleeping-sickness-treatment.aspx The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has granted a positive opinion to Acoziborole Winthrop (acoziborole) as a single-dose oral treatment for both early- and advanced-stage gambiense sleeping sickness in adults as well as in adolescents 12 years and older weighing at least 40 kilograms.